Lyka Labs · NSE: LYKALABS · BSE: 500259
Q4 FY25 results · Jan–Mar 2025
Lyka Labs reported revenue from operations of ₹33.43 crore (up 20.4% from Q4 FY24) and net profit of ₹2.03 crore for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 33.43 | 27.77 | +20.4% | 33.80 | −1.1% |
| Other income | 0.82 | 0.29 | +181.9% | 0.83 | −0.7% |
| Total income | 34.25 | 28.06 | +22.1% | 34.62 | −1.1% |
| Profit before tax | 3.02 | (1.68) | Turned profit | 3.57 | −15.5% |
| Net profit for the period | 2.03 | (2.14) | Turned profit | 2.70 | −25.0% |
| Attributable to shareholders of the company | 1.77 | — | — | 2.69 | −34.2% |
| EPS, basic (₹) | 0.49 | (3.83) | Turned profit | 0.75 | −34.7% |
| Net margin (%) | 6.1 | -7.7 | 8.0 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 30.52 | 26.98 | +13.1% | 32.92 | −7.3% |
| Other income | 0.72 | 0.39 | +84.9% | 0.87 | −17.6% |
| Total income | 31.24 | 27.37 | +14.1% | 33.80 | −7.6% |
| Profit before tax | 2.27 | (1.21) | Turned profit | 3.59 | −36.7% |
| Net profit for the period | 1.31 | (1.62) | Turned profit | 2.70 | −51.6% |
| EPS, basic (₹) | 0.36 | (0.50) | Turned profit | 0.75 | −52.0% |
| Net margin (%) | 4.3 | -6.0 | 8.2 |
Consolidated
- Filed with BSE
- 26 May 2025, 20:14 IST
- Board meeting
- 22 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 26 May 2025, 20:14 IST
- Board meeting
- 26 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE